| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Tau Peptide (268-282) |
|
330456-37-6 |
詳細(xì)
|
| Ac-Tyr-Lys-NH2 |
|
270597-64-3 |
詳細(xì)
|
| Substance P (7-11) |
|
51165-05-0 |
詳細(xì)
|
| (Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) |
|
2022956-55-2 |
詳細(xì)
|
| Tau Peptide (306-317) |
|
1003007-59-7 |
詳細(xì)
|
| Tau Peptide (74-102) (Exon 3/Insert 2 Domain) |
|
1322695-34-0 |
詳細(xì)
|
| Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) |
|
2022956-58-5 |
詳細(xì)
|
| Tau Peptide (306-336) (Repeat 3 Domain) |
|
330456-26-3 |
詳細(xì)
|
| Tau Peptide (379-408) |
|
1246357-53-8 |
詳細(xì)
|
| Tau Peptide (307-321) |
|
330456-50-3 |
詳細(xì)
|
| Tau Peptide (337-368) (Repeat 4 Domain) |
|
330456-27-4 |
詳細(xì)
|
| Tau Peptide (323-335) |
|
2022956-59-6 |
詳細(xì)
|
| H-Leu-Ser-Lys-Leu-OH |
|
162559-45-7 |
詳細(xì)
|
| LSKL, Inhibitor of Thrombospondin TSP-1 |
|
283609-79-0 |
詳細(xì)
|
| T-peptide |
|
2022956-62-1 |
詳細(xì)
|
| Lys-Trp-Lys-(Ser(GlcNAc-β-D)400)-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide |
|
2022974-40-7 |
詳細(xì)
|
| Tau Peptide (512-525) amide |
|
2022956-61-0 |
詳細(xì)
|
| (Ser(PO3H2)396.404)-Tau Peptide (379-408) |
|
2022956-60-9 |
詳細(xì)
|
| H-Leu-Ser-Ala-Leu-OH |
|
169249-03-0 |
詳細(xì)
|
| Tau Peptide (472-487)-PEG6-(507-526) (human) |
|
2243219-84-1 |
詳細(xì)
|
| Charybdotoxin |
|
95751-30-7 |
詳細(xì)
|
| TRH |
|
24305-27-9 |
詳細(xì)
|
| TRH-AMC |
|
190836-86-3 |
詳細(xì)
|
| u-Conotoxin GIIIA |
|
129129-65-3 |
詳細(xì)
|
| Chlorotoxin |
|
163515-35-3 |
詳細(xì)
|
| α-Conotoxin EI (free acid) |
|
1926163-14-5 |
詳細(xì)
|
| α-Conotoxin MI |
|
88217-10-1 |
詳細(xì)
|
| ω-Agatoxin IVA |
|
145017-83-0 |
詳細(xì)
|
| Conantokin G (free acid) |
|
133628-78-1 |
詳細(xì)
|
| TRH-βNA |
|
73644-58-3 |
詳細(xì)
|
| u-Conotoxin GIIIB| MU-CONOTOXIN GIIIB |
|
140678-12-2 |
詳細(xì)
|
| H-His-Pro-NH2 |
|
59760-04-2 |
詳細(xì)
|
| TRH-Gly |
|
85344-77-0 |
詳細(xì)
|
| ω-Conotoxin GVIA |
|
106375-28-4 |
詳細(xì)
|
| (Lys1015.1024)-Thrombospondin-1 (1015-1024) (human, bovine, mouse) |
|
178921-95-4 |
詳細(xì)
|
| Arg8]-Conopressin G |
|
130836-24-7 |
詳細(xì)
|
| ω-Conotoxin MVIIC|OMEGA-CONOTOXIN MVIIC |
|
147794-23-8 |
詳細(xì)
|
| Tertiapin |
|
58694-52-3 |
詳細(xì)
|
| Urotensin II,human |
|
251293-28-4 |
詳細(xì)
|
| SB-710411 |
|
209006-05-3 |
詳細(xì)
|
| Stichodactyla helianthus Neurotoxin (ShK) |
|
172450-46-3 |
詳細(xì)
|
| Copeptin (human) |
|
78362-34-2 |
詳細(xì)
|
| Tertiapin Q |
|
910044-56-3 |
詳細(xì)
|
| Mast Cell Degranulating (MCD) Peptide HR-2 |
|
80388-04-1 |
詳細(xì)
|
| Urotensin II-Related Peptide (human, mouse, rat) |
|
342878-90-4 |
詳細(xì)
|
| (Dap22)-Stichodactyla helianthus Neurotoxin (ShK) |
|
220384-25-8 |
詳細(xì)
|
| Urotensin II (goby) |
|
9047-55-6 |
詳細(xì)
|
| ω-Agatoxin TK |
|
158484-42-5 |
詳細(xì)
|
| Mast Cell Degranulating (MCD) Peptide |
|
32908-73-9 |
詳細(xì)
|
| Sarafotoxin S6b |
|
120972-53-4 |
詳細(xì)
|
| Biotin-Ahx-ω-Conotoxin GVIA |
|
151928-23-3 |
詳細(xì)
|
| (Lys4)-Sarafotoxin C |
|
1219444-22-0 |
詳細(xì)
|
| Urotensin I |
|
83930-33-0 |
詳細(xì)
|
| Copeptin (rat) |
|
86280-64-0 |
詳細(xì)
|
| Toxin GaTx1 |
|
1926163-15-6 |
詳細(xì)
|
| ((R)-4-Hydroxy-4-methyl-Orn7)-Phalloidin |
|
87876-22-0 |
詳細(xì)
|
| Phalloidin |
|
17466-45-4 |
詳細(xì)
|
| Mast Cell Degranulating (MCD) Peptide HR-1 |
|
80533-94-4 |
詳細(xì)
|
| 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) |
|
1927927-42-1 |
詳細(xì)
|
| (PEN)-UROTENSIN II (4-11) |
|
473902-31-7 |
詳細(xì)
|
| Iberiotoxin |
|
129203-60-7 |
詳細(xì)
|
| (Pyr1)-Urotensin II (rat) |
|
405136-99-4 |
詳細(xì)
|
| Sarafotoxin S6a |
|
126738-34-9 |
詳細(xì)
|
| α-Dendrotoxin |
|
74504-53-3 |
詳細(xì)
|
| Sarafotoxin 6c |
|
121695-87-2 |
詳細(xì)
|
| Arg8]-Vasopressin (4-9) |
|
96027-30-4 |
詳細(xì)
|
| (Deamino-Cys1,Val4,D-Arg8)-Vasopressin |
|
43157-23-9 |
詳細(xì)
|
| LQEQ-19 (mouse, rat) |
|
322644-72-4 |
詳細(xì)
|
| AQEE-30 (human) |
|
160046-70-8 |
詳細(xì)
|
| (d(CH2)51,D-Phe2,Ile4,Ala-NH2)-Vasopressin |
|
99835-78-6 |
詳細(xì)
|
| AQEE-30 (mouse, rat) |
|
323185-80-4 |
詳細(xì)
|
| (1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin |
|
112465-00-6 |
詳細(xì)
|
| (d(CH2)51,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin |
|
90332-82-4 |
詳細(xì)
|
| (d(CH2)51,D-Ile2,Ile4,Arg8)-Vasopressin |
|
88686-53-7 |
詳細(xì)
|
| (Deamino-Cys1,D-Orn8)-Vasopressin |
|
60498-04-6 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin |
|
129520-65-6 |
詳細(xì)
|
| d[Cha4]-AVP |
|
500170-27-4 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-2 (human) |
|
1872441-23-0 |
詳細(xì)
|
| Boc-Pressinoic acid |
|
72287-67-3 |
詳細(xì)
|
| (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin |
|
73168-24-8 |
詳細(xì)
|
| (Propionyl1,D-Tyr(Et)2,Val4,Abu6,Arg8.9)-Vasopressin |
|
121250-95-1 |
詳細(xì)
|
| (d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin |
|
90332-81-3 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-1 (rat) |
|
954420-51-0 |
詳細(xì)
|
| Biotin-(Arg8)-Vasopressin |
|
126703-17-1 |
詳細(xì)
|
| 3-(4-Azidophenyl)propionyl1,D-Tyr(Me)2,Arg6,Arg8,Tyr-NH)-Vasopressin |
|
157702-46-0 |
詳細(xì)
|
| (Deamino-Pen1,Val4,D-Arg8)-Vasopressin |
|
64158-84-5 |
詳細(xì)
|
| (d(CH2)51,D-Ile2,Ile4,Arg8,Ala-NH2)-Vasopressin |
|
114455-29-7 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-2 (rat) |
|
1872441-24-1 |
詳細(xì)
|
| d[Leu4,Lys8]-VP |
|
42061-33-6 |
詳細(xì)
|
| (d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly-NH2)-Vasopressin |
|
110567-67-4 |
詳細(xì)
|
| (3,5-Diiodo-Tyr2,Arg8)-Vasopressin |
|
63441-67-8 |
詳細(xì)
|
| (Arg8)-Vasopressin (free acid) |
|
25255-33-8 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Me)2,Arg6.8,Tyr-NH2)-Vasopressin |
|
135447-36-8 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-1 (human) |
|
954420-50-9 |
詳細(xì)
|
| (Deamino-Cys1,Lys8)-Vasopressin |
|
2989-84-6 |
詳細(xì)
|
| (Deamino-Pen1,Tyr(Me)2,Arg8)-Vasopressin |
|
67269-08-3 |
詳細(xì)
|
| (Deamino-Cys1,β-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin |
|
136105-89-0 |
詳細(xì)
|
| des-Gly9 NH2 Vasopressin |
|
37552-33-3 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Me)2,Arg6.8,Lys-NH2)-Vasopressin |
|
148565-73-5 |
詳細(xì)
|
| Gly-Neuroendocrine Regulatory Peptide-3 (human, mouse, rat) |
|
1815618-19-9 |
詳細(xì)
|